Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DESIGN VERIFICATION/VALIDATION GUIDANCE, FOUR OTHERS UNDER CONSIDERATION BY FDA; AGENCY TO TAKE "CAUTIOUS" APPROACH TO DESIGN CONTROL ENFORCEMENT AFTER JUNE 1

This article was originally published in The Gray Sheet

Executive Summary

Additional guidance on design verification/validation may be developed by FDA to give device manufacturers added direction on complying with design control requirements under the quality system regulation, agency staffers indicated at a Feb. 2 meeting at the National Institutes of Health campus in Bethesda, Maryland.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009534

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel